Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Molecular pathways: beta-adrenergic signaling in cancer.

Cole SW, Sood AK.

Clin Cancer Res. 2012 Mar 1;18(5):1201-6. doi: 10.1158/1078-0432.CCR-11-0641. Epub 2011 Dec 20. Review.

2.

β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy.

Tang J, Li Z, Lu L, Cho CH.

Semin Cancer Biol. 2013 Dec;23(6 Pt B):533-42. doi: 10.1016/j.semcancer.2013.08.009. Epub 2013 Sep 4. Review.

3.

The role of adrenergic signaling in breast cancer biology.

Obeid EI, Conzen SD.

Cancer Biomark. 2013;13(3):161-9. doi: 10.3233/CBM-130347. Review.

PMID:
23912488
4.

β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.

Coelho M, Soares-Silva C, Brandão D, Marino F, Cosentino M, Ribeiro L.

J Cancer Res Clin Oncol. 2017 Feb;143(2):275-291. doi: 10.1007/s00432-016-2278-1. Epub 2016 Oct 5. Review.

PMID:
27709364
5.

Intercepting neoplastic progression in lung malignancies via the beta adrenergic (β-AR) pathway: implications for anti-cancer drug targets.

Al-Wadei HA, Ullah MF, Al-Wadei MH.

Pharmacol Res. 2012 Jul;66(1):33-40. doi: 10.1016/j.phrs.2012.03.014. Epub 2012 Apr 2. Review.

PMID:
22487140
6.

Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment.

Kim-Fuchs C, Le CP, Pimentel MA, Shackleford D, Ferrari D, Angst E, Hollande F, Sloan EK.

Brain Behav Immun. 2014 Aug;40:40-7. doi: 10.1016/j.bbi.2014.02.019. Epub 2014 Mar 17.

7.

The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference.

He RH, He YJ, Tang YJ, Zhou HH, McLeod HL, Liu J.

Pharmacogenomics. 2016;17(1):74-9. doi: 10.2217/pgs.15.152. Epub 2015 Dec 14. Review.

PMID:
26652861
8.

Beta-adrenergic signaling, a novel target for cancer therapy?

Schuller HM.

Oncotarget. 2010 Nov;1(7):466-9. No abstract available.

9.

The impact of adrenergic signaling in skin cancer progression: possible repurposing of β-blockers for treatment of skin cancer.

Yang EV, Eubank TD.

Cancer Biomark. 2013;13(3):155-60. doi: 10.3233/CBM-130325. Review.

PMID:
23912487
10.

Src activation by β-adrenoreceptors is a key switch for tumour metastasis.

Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, Soman KV, Shahzad MM, Zigler M, Deavers MT, Zien A, Soldatos TG, Jackson DB, Wiktorowicz JE, Torres-Lugo M, Young T, De Geest K, Gallick GE, Bar-Eli M, Lopez-Berestein G, Cole SW, Lopez GE, Lutgendorf SK, Sood AK.

Nat Commun. 2013;4:1403. doi: 10.1038/ncomms2413. Erratum in: Nat Commun. 2013;4:1932. Shazhad, Mian M K [corrected to Shahzad, Mian M K].

11.

The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options.

Colucci R, Moretti S.

J Cancer Res Clin Oncol. 2016 May;142(5):1021-9. doi: 10.1007/s00432-015-2078-z. Epub 2015 Nov 23. Review.

PMID:
26597413
12.

[Stress and pancreatic carcinoma--β-adrenergic signaling and tumor biology].

Hefner J, Csef H, Kunzmann V.

Dtsch Med Wochenschr. 2014 Feb;139(7):334-8. doi: 10.1055/s-0033-1360039. Epub 2014 Feb 4. Review. German.

PMID:
24496896
13.

Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling.

Lamkin DM, Sloan EK, Patel AJ, Chiang BS, Pimentel MA, Ma JC, Arevalo JM, Morizono K, Cole SW.

Brain Behav Immun. 2012 May;26(4):635-41. doi: 10.1016/j.bbi.2012.01.013. Epub 2012 Jan 25.

14.

Adrenergic modulation of survival and cellular immune functions during polymicrobial sepsis.

Oberbeck R, Schmitz D, Wilsenack K, Schüler M, Pehle B, Schedlowski M, Exton MS.

Neuroimmunomodulation. 2004;11(4):214-23.

PMID:
15249727
15.

The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms.

Lương Kv, Nguyen LT.

Am J Alzheimers Dis Other Demen. 2013 Aug;28(5):427-39. doi: 10.1177/1533317513488924. Epub 2013 May 20. Review.

PMID:
23689075
16.

Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications.

Tortora G, Ciardiello F, Gasparini G.

Nat Clin Pract Oncol. 2008 Sep;5(9):521-30. doi: 10.1038/ncponc1161. Epub 2008 Jul 1. Review.

PMID:
18594498
17.

α2-Adrenergic blockade mimics the enhancing effect of chronic stress on breast cancer progression.

Lamkin DM, Sung HY, Yang GS, David JM, Ma JC, Cole SW, Sloan EK.

Psychoneuroendocrinology. 2015 Jan;51:262-70. doi: 10.1016/j.psyneuen.2014.10.004. Epub 2014 Oct 12.

18.

β-adrenergic-blocking drugs and melanoma: current state of the art.

De Giorgi V, Grazzini M, Gandini S, Benemei S, Asbury CD, Marchionni N, Geppetti P.

Expert Rev Anticancer Ther. 2012 Nov;12(11):1461-7. doi: 10.1586/era.12.118. Review.

PMID:
23249110
19.
20.

Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy.

Böhm M, Ettelbrück S, Flesch M, van Gilst WH, Knorr A, Maack C, Pinto YM, Paul M, Teisman AC, Zolk O.

Cardiovasc Res. 1998 Oct;40(1):146-55.

PMID:
9876327

Supplemental Content

Support Center